CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Zealand Pharma A/S/ADR

ZLDPF
$2.89BMid Cap

Next catalyst

No upcoming catalyst in our data

No upcoming FDA decision, filing or trial readout is on file for ZLDPF. That does not mean none is planned.

Get an email about ZLDPF's next catalysts

Track Zealand Pharma A/S/ADR (ZLDPF) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.

Catalyst Timeline

0 upcoming, 0 past

No catalysts found.

Market Overview

Stock performance and key metrics

NASDAQBiotechnologyπŸ‡ΊπŸ‡ΈNorth AmericaSOBORG578 employees
Drug Pipeline

Frequently asked questions

What is in Zealand Pharma A/S/ADR's drug pipeline?β†’

CatalystAlert tracks 7 drug candidates in Zealand Pharma A/S/ADR's (ZLDPF) pipeline across Phase 3, Phase 2. Its lead program is dasiglucagon (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.

When is Zealand Pharma A/S/ADR's next FDA catalyst?β†’

CatalystAlert tracks every upcoming catalyst for Zealand Pharma A/S/ADR (ZLDPF) β€” PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings β€” each confidence-rated as confirmed, estimated or AI-detected.

How do I track ZLDPF biotech catalysts?β†’

Add ZLDPF to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Zealand Pharma A/S/ADR's live catalyst calendar, drug pipeline and clinical-trial timeline on this page β€” sourced from ClinicalTrials.gov, FDA and SEC filings.

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply